Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Hepatic stellate cells: partners in crime for liver metastases?

Kang N, Gores GJ, Shah VH.

Hepatology. 2011 Aug;54(2):707-13. doi: 10.1002/hep.24384. Review.

2.

Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors.

Tu K, Li J, Verma VK, Liu C, Billadeau DD, Lamprecht G, Xiang X, Guo L, Dhanasekaran R, Roberts LR, Shah VH, Kang N.

Hepatology. 2015 Jan;61(1):361-74. doi: 10.1002/hep.27251. Epub 2014 Sep 19.

3.

Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.

Mikuriya Y, Tashiro H, Kuroda S, Nambu J, Kobayashi T, Amano H, Tanaka Y, Ohdan H.

Int J Cancer. 2015 Feb 15;136(4):E3-13. doi: 10.1002/ijc.29096. Epub 2014 Aug 4.

4.

Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.

Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F.

Gut. 2012 Oct;61(10):1465-72. doi: 10.1136/gutjnl-2011-300810. Epub 2011 Nov 9.

PMID:
22071959
5.

Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.

Song J, Ge Z, Yang X, Luo Q, Wang C, You H, Ge T, Deng Y, Lin H, Cui Y, Chu W, Yao M, Zhang Z, Gu J, Fan J, Qin W.

Cancer Lett. 2015 Jan 28;356(2 Pt B):713-20. doi: 10.1016/j.canlet.2014.10.021. Epub 2014 Oct 27.

PMID:
25449435
6.

In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells.

Shimizu S, Yamada N, Sawada T, Ikeda K, Kawada N, Seki S, Kaneda K, Hirakawa K.

Jpn J Cancer Res. 2000 Dec;91(12):1285-95.

PMID:
11123428
7.

Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.

Han S, Han L, Yao Y, Sun H, Zan X, Liu Q.

Oncol Rep. 2014 Feb;31(2):641-8. doi: 10.3892/or.2013.2872. Epub 2013 Nov 27.

PMID:
24284889
8.

Proof of prometastatic niche induction by hepatic stellate cells.

Eveno C, Hainaud P, Rampanou A, Bonnin P, Bakhouche S, Dupuy E, Contreres JO, Pocard M.

J Surg Res. 2015 Apr;194(2):496-504. doi: 10.1016/j.jss.2014.11.005. Epub 2014 Nov 10.

PMID:
25528682
9.

Hepatic stellate cells--the pericytes in the liver.

Hellerbrand C.

Pflugers Arch. 2013 Jun;465(6):775-8. doi: 10.1007/s00424-012-1209-5. Epub 2013 Jan 5. Review.

PMID:
23292551
10.

Wnt signaling in liver fibrosis: progress, challenges and potential directions.

Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J.

Biochimie. 2013 Dec;95(12):2326-35. doi: 10.1016/j.biochi.2013.09.003. Epub 2013 Sep 13. Review.

PMID:
24036368
11.

Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?

Kang N, Shah VH, Urrutia R.

Mol Cancer Res. 2015 Apr;13(4):604-12. doi: 10.1158/1541-7786.MCR-14-0542. Epub 2014 Dec 29. Review.

13.

Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS.

Int J Cancer. 2014 Feb 15;134(4):778-88. doi: 10.1002/ijc.28421. Epub 2013 Sep 16.

14.

Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.

Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, García-Rodríguez JL, Embade N, Fernández-Ramos D, Martínez-López N, Gutiérrez-De Juan V, Arteta B, Caballeria J, Lu SC, Mato JM, Varela-Rey M, Martínez-Chantar ML.

Hepatology. 2012 Nov;56(5):1870-82. doi: 10.1002/hep.25828. Epub 2012 Oct 9.

15.

Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.

Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F.

Hepatology. 2003 Mar;37(3):674-85.

PMID:
12601365
16.

Apoptotic and survival signals in hepatic stellate cells.

Shen H, Fan J, Minuk G, Gong Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Oct;32(5):726-34. Review.

17.

Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.

Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou C, You J, Fan J, Wang X.

Int J Cancer. 2011 Dec 1;129(11):2651-61. doi: 10.1002/ijc.25920. Epub 2011 Mar 25.

18.

Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.

Lei XF, Fu W, Kim-Kaneyama JR, Omoto T, Miyazaki T, Li B, Miyazaki A.

J Hepatol. 2016 Jan;64(1):110-7. doi: 10.1016/j.jhep.2015.08.026. Epub 2015 Aug 31.

PMID:
26334580
19.

Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway.

Zhang LT, Fang XQ, Chen QF, Chen H, Xiao P, Peng XB, Zhang SX, Li JF, Mao XR.

Mol Med Rep. 2015 Nov;12(5):7227-32. doi: 10.3892/mmr.2015.4362. Epub 2015 Sep 25.

20.

Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays.

Xiong WJ, Hu LJ, Jian YC, Wang LJ, Jiang M, Li W, He Y.

World J Gastroenterol. 2012 Apr 21;18(15):1745-52. doi: 10.3748/wjg.v18.i15.1745.

Supplemental Content

Support Center